{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:13:42Z","timestamp":1793150022655,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aohep.2025.102122","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:24:51Z","timestamp":1757859891000},"page":"102122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnosis of metabolic dysfunction-associated steatotic liver disease by triglyceride glucose-body mass index: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"31","author":[{"given":"Kexin","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.aohep.2025.102122_bib0001","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101133","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2025.102122_bib0003","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10464","key":"10.1016\/j.aohep.2025.102122_bib0004","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2025.102122_bib0006","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0007","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12944-022-01661-7","article-title":"Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study","volume":"21","author":"Liu","year":"2022","journal-title":"Lipids Health Dis"},{"issue":"3","key":"10.1016\/j.aohep.2025.102122_bib0008","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/met.2020.0109","article-title":"Triglyceride glucose index and related parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight\/obesity","volume":"19","author":"Khamseh","year":"2021","journal-title":"Metab Syndr Relat Disord"},{"issue":"7","key":"10.1016\/j.aohep.2025.102122_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12902-022-00993-w","article-title":"Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes","volume":"22","author":"Li","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.aohep.2025.102122_bib0011","article-title":"Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus","volume":"15","author":"Qian","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"16","key":"10.1016\/j.aohep.2025.102122_bib0012","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.2169\/internalmedicine.1097-22","article-title":"Utility of indices obtained during medical checkups for predicting fatty liver disease in non-obese people","volume":"62","author":"Otsubo","year":"2023","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0013","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","article-title":"The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease","volume":"20","author":"Sheng","year":"2021","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.aohep.2025.102122_bib0014","article-title":"The triglyceride glucose-waist circumference is the best indicator for screening non-alcoholic fatty liver disease in middle-aged and elderly people","author":"Yang","year":"2025","journal-title":"Nutr Hosp"},{"issue":"9","key":"10.1016\/j.aohep.2025.102122_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092251","article-title":"Triglyceride glucose-waist circumference (TyG-WC) is a reliable marker to predict non-alcoholic fatty liver disease","volume":"10","author":"Song","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0016","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12967-022-03611-4","article-title":"The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population","volume":"20","author":"Hu","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.aohep.2025.102122_bib0017","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2147\/DMSO.S409983","article-title":"Relationship between six insulin resistance surrogates and nonalcoholic fatty liver disease among older adults: a cross-sectional study","volume":"16","author":"Li","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"23","key":"10.1016\/j.aohep.2025.102122_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13237423","article-title":"Predictive value of TyG and TyG-BMI Indices for non-alcoholic fatty liver disease in high-altitude regions of china: a cross-sectional study","volume":"13","author":"Wang","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0019","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13098-024-01571-x","article-title":"Prediction of MASLD using different screening indexes in Chinese type 2 diabetes mellitus","volume":"17","author":"Hu","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.aohep.2025.102122_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1083032","article-title":"Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults","volume":"14","author":"Peng","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.aohep.2025.102122_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.951689","article-title":"Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters","volume":"13","author":"Xue","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0022","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12902-024-01794-z","article-title":"The potential of insulin resistance indices to predict non-alcoholic fatty liver disease in patients with type 2 diabetes","volume":"24","author":"Tian","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.aohep.2025.102122_bib0023","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2147\/DMSO.S418020","article-title":"Non-traditional blood lipid indices for metabolism dysfunction-associated fatty liver disease prediction in non-obese type 2 diabetes mellitus","volume":"16","author":"Gao","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.aohep.2025.102122_bib0024","article-title":"Modified triglyceride-glucose index indices are reliable markers for predicting risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study","volume":"14","author":"Kim","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.aohep.2025.102122_bib0025","doi-asserted-by":"crossref","first-page":"e456","DOI":"10.1002\/edm2.456","article-title":"Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients","volume":"6","author":"Bockarie","year":"2023","journal-title":"Endocrinol Diabetes Metab"},{"issue":"9","key":"10.1016\/j.aohep.2025.102122_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-075413","article-title":"Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study","volume":"13","author":"Yu","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41598-024-84809-y","article-title":"Correlation analysis of the triglyceride-glucose index and related parameters in metabolic dysfunction-associated fatty liver disease","volume":"15","author":"Yang","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0028","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/s12889-023-15365-9","article-title":"Comparison of the prognostic value of a comprehensive set of predictors in identifying risk of metabolic-associated fatty liver disease among employed adults","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0029","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12944-023-01902-3","article-title":"Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease","volume":"22","author":"Zou","year":"2023","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0030","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1038\/s41598-025-88478-3","article-title":"Association between TyG-related parameters and NAFLD risk in Japanese non-obese population","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0031","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1038\/s41598-024-84917-9","article-title":"Association between TyG related parameters and metabolic dysfunction associated fatty liver disease among nondiabetic individuals","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0032","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12944-023-01954-5","article-title":"Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease","volume":"22","author":"Wang","year":"2023","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.aohep.2025.102122_bib0033","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s10620-024-08309-9","article-title":"Insulin resistance\/sensitivity measures as screening indicators of metabolic-associated fatty liver disease and liver fibrosis","volume":"69","author":"Khamseh","year":"2024","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.aohep.2025.102122_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102400","article-title":"Diagnostic performance of sixteen biomarkers for MASLD: a study in a Mexican cohort","volume":"48","author":"Priego-Parra","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102122_bib0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s13410-023-01255-8","article-title":"Correlation between triglyceride-glucose index and related parameters and nonalcoholic fatty liver disease in northwest China","volume":"44","author":"Li","year":"2024","journal-title":"Int J Diabetes Dev Ctries"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0036","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s12876-025-04087-4","article-title":"TyG-BMI as a superior predictor of MAFLD and pre-MAFLD in Chinese adults: a cross-sectional study","volume":"25","author":"Huang","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.aohep.2025.102122_bib0037","doi-asserted-by":"crossref","DOI":"10.1155\/cjgh\/5871321","article-title":"The value of TyG-related indices in evaluating MASLD and significant liver fibrosis in MASLD","volume":"2025","author":"Zou","year":"2025","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2025.102122_bib0038","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070189","article-title":"Association between triglyceride glucose-related markers and the risk of metabolic-associated fatty liver disease: a cross-sectional study in healthy Chinese participants","volume":"13","author":"Chang","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0039","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12933-024-02392-y","article-title":"Diagnostic and prognostic value of triglyceride glucose index: a comprehensive evaluation of meta-analysis","volume":"23","author":"Nayak","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.aohep.2025.102122_bib0040","article-title":"The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose-response meta-analysis","volume":"13","author":"Ling","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0041","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12933-025-02716-6","article-title":"Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study","volume":"24","author":"Song","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0042","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jgh.13857","article-title":"Asia-Pacific working party on non-alcoholic fatty liver disease guidelines 2017-Part 1: definition, risk factors and assessment","volume":"33","author":"Wong","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0043","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s12967-020-02637-w","article-title":"Circular RNA expression profiles and features in NAFLD mice: a study using RNA-seq data","volume":"18","author":"Yuan","year":"2020","journal-title":"J Transl Med"},{"issue":"11","key":"10.1016\/j.aohep.2025.102122_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113863","article-title":"The role of insulin resistance and diabetes in nonalcoholic fatty liver disease","volume":"21","author":"Fujii","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.aohep.2025.102122_bib0045","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1016\/j.aohep.2025.102122_bib0046","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/hep.29420","article-title":"Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis","volume":"66","author":"Bhanji","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2025.102122_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2015.03.002","article-title":"Quantification of pyrophosphate as a universal approach to determine polymerase activity and assay polymerase inhibitors","volume":"478","author":"Malvezzi","year":"2015","journal-title":"Anal Biochem"},{"key":"10.1016\/j.aohep.2025.102122_bib0048","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-3-319-70178-3_9","article-title":"Sex differences in muscle wasting","volume":"1043","author":"Anderson","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.aohep.2025.102122_bib0049","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/obr.12407","article-title":"Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies","volume":"17","author":"Li","year":"2016","journal-title":"Obes Rev"},{"issue":"1 Pt 1","key":"10.1016\/j.aohep.2025.102122_bib0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults","volume":"21","author":"Park","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102122_bib0051","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gutjnl-2011-300342","article-title":"Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.aohep.2025.102122_bib0052","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00535-012-0533-z","article-title":"Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study","volume":"47","author":"Eguchi","year":"2012","journal-title":"J Gastroenterol"},{"issue":"9","key":"10.1016\/j.aohep.2025.102122_bib0053","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/MEG.0000000000000151","article-title":"Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China","volume":"26","author":"Wang","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.aohep.2025.102122_bib0054","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/liv.13709","article-title":"A simple clinical model predicts incident hepatic steatosis in a community-based cohort: the framingham heart study","volume":"38","author":"Long","year":"2018","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.aohep.2025.102122_bib0055","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jhep.2011.12.011","article-title":"Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up","volume":"56","author":"Zelber-Sagi","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2025.102122_bib0056","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-230X-12-84","article-title":"Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline","volume":"12","author":"Sung","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0057","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","article-title":"Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial","volume":"65","author":"McKenzie","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0058","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cgh.2016.07.034","article-title":"Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis","volume":"15","author":"Yang","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102122_bib0059","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/hepr.13282","article-title":"Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non-alcoholic fatty liver disease","volume":"49","author":"Tanaka","year":"2019","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.28514","article-title":"A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease","volume":"64","author":"Klair","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2025.102122_bib0061","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev.nu.09.070189.002221","article-title":"Physiologic basis for the control of body fat distribution in humans","volume":"9","author":"Leibel","year":"1989","journal-title":"Annu Rev Nutr"},{"issue":"4","key":"10.1016\/j.aohep.2025.102122_bib0062","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1210\/jc.2003-031327","article-title":"Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution","volume":"89","author":"Pedersen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.aohep.2025.102122_bib0063","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176446","article-title":"Estradiol-mediated improvements in adipose tissue insulin sensitivity are related to the balance of adipose tissue estrogen receptor \u03b1 and \u03b2 in postmenopausal women","volume":"12","author":"Park","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.aohep.2025.102122_bib0064","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2025.102122_bib0065","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2796.2009.02162.x","article-title":"Menopause impacts the relation of plasma adiponectin levels with the metabolic syndrome","volume":"267","author":"Henneman","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.aohep.2025.102122_bib0066","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-nutr-071816-064827","article-title":"Genetic Basis for Sex Differences in Obesity and Lipid Metabolism","volume":"37","author":"Link","year":"2017","journal-title":"Annu Rev Nutr"},{"issue":"10","key":"10.1016\/j.aohep.2025.102122_bib0067","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/humrep\/deu198","article-title":"The striking similarities in the metabolic associations of female androgen excess and male androgen deficiency","volume":"29","author":"Escobar-Morreale","year":"2014","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.aohep.2025.102122_bib0068","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.26761","article-title":"Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.aohep.2025.102122_bib0069","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.aohep.2025.102122_bib0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2288-11-158","article-title":"Selection of the appropriate method for the assessment of insulin resistance","volume":"11","author":"Borai","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102122_bib0071","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1016\/j.aohep.2025.102122_bib0072","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/jcem-54-2-254","article-title":"Relation of body fat distribution to metabolic complications of obesity","volume":"54","author":"Kissebah","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.aohep.2025.102122_bib0073","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1016\/j.jhep.2024.12.025","article-title":"Not all fat is alike in MASLD","volume":"82","author":"Lonardo","year":"2025","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2025.102122_bib0074","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","article-title":"Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome","volume":"21","author":"Wajchenberg","year":"2000","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.aohep.2025.102122_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149731","article-title":"Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in Nondiabetic individuals","volume":"11","author":"Er","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2025.102122_bib0076","doi-asserted-by":"crossref","DOI":"10.1177\/17562848241276334","article-title":"Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques","volume":"17","author":"Hudson","year":"2024","journal-title":"Ther Adv Gastroenterol"},{"issue":"4","key":"10.1016\/j.aohep.2025.102122_bib0077","article-title":"Non-invasive tests as a replacement for liver biopsy in the assessment of MASLD","volume":"61","author":"Fr\u0105czek","year":"2025","journal-title":"Med (Kaunas)"},{"issue":"1","key":"10.1016\/j.aohep.2025.102122_bib0078","first-page":"7","article-title":"Diagnostic accuracy of ultrasonography for the detection of hepatic steatosis: an updated meta-analysis of observational studies","volume":"1","author":"Stefano","year":"2021","journal-title":"Metab Target Organ Damage"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:48:51Z","timestamp":1780649331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125003473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1665268125003473"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102122","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis of metabolic dysfunction-associated steatotic liver disease by triglyceride glucose-body mass index: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102122"}}